The Latest Cardiac and Vascular News
ECGenius Sets a New Standard for ECG Signal Detection, Interpretation and Therapy Support COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System. ECGenius, the company’s innovative EP recording technology […]
University of Vermont Medical Center Initiates Evaluation of the ECGenius System as CathVision Prepares for U.S. Launch COPENHAGEN, Denmark, April 26, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, today announced the completion of patient enrollment in the CathVision ECGenius […]
Researchers to Examine Efficacy of Using AI Algorithm to Confirm Pulmonary Vein Isolation COPENHAGEN, Denmark and MINNETONKA, Minn., Oct. 26, 2021 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions in EP recording technology, today announced the first patient enrollments in the PVISION multicenter clinical study. The newly launched trial will investigate the automated assessment of pulmonary vein […]
COPENHAGEN, Denmark, March 16, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, is announcing a change to its Board of Directors. Meghna Eichelberger, Partner and Associate Director of Medical Technologies, at The Boston Consulting Group (BCG), has joined CathVision’s Board of Directors. Meghna adds a […]
COPENHAGEN, Denmark, Jan. 29, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, is featured at the 26th annual international AF Symposium, held online January 29-31st. On January 30th, Professor Josef Kautzner, Institute of Cardiology and Experimental Medicine (IKEM), Czech Republic, will present the […]
COPENHAGEN, May 19, 2020 /PRNewswire/ — CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed an investment round of a total 13M euro. Both existing and new investors participated in the round. The proceeds allow the company to begin multi-center clinical studies and complete its FDA approval process for […]
COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME Instrument, Phase 2 under the Horizon2020 programme. There were approximately 5,000 […]
COPENHAGEN, Denmark, May 27, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac amplifier and electrophysiology products, announced today the addition of two industry leaders to its Board of Directors. Søren Thestrup-Nielsen, MD, was elected Chairman of the Board, and Denis Gestin was elected Member of the Board. Soren Thestrup-Nielsen, MD, has spent 25 years […]
COPENHAGEN, Denmark, October 2, 2018 /PRNewswire/ — CathVision ApS, an early stage medical device company developing an advanced cardiac electrophysiology recording system, CUBE, announced today that the company received ISO 13485:2016 certification for Medical Device and Quality Management Systems from Lloyd’s Register. This ISO certification indicates that the company’s quality management system meets the most current regulatory requirements specific […]
COPENHAGEN, Denmark, July 7, 2017 /PRNewswire/ — Medical device company CathVision has signed a multi-million venture investment from Scandinavian-based investors VF Venture and Borean Innovation. The investment is directed at developing and market the company’s superior electrophysiology (EP) recording system for treating cardiac arrhythmia. Approximately 2% of the Western population suffers from cardiac arrhythmia, and hospital-based catheter ablation […]
